BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23126479)

  • 1. There is no evidence for an association between the serotonin receptor 3A gene C178T polymorphism and tardive dyskinesia in Korean schizophrenia patients.
    Kang SG; Lee HJ; Yoon HK; Cho SN; Park YM; Kim L
    Nord J Psychiatry; 2013 Jun; 67(3):214-8. PubMed ID: 23126479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.
    Lee HJ; Kang SG; Choi JE; Paik JW; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2007; 55(1):47-51. PubMed ID: 17556853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.
    Woo SI; Kim JW; Rha E; Han SH; Hahn KH; Park CS; Sohn JW
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):469-74. PubMed ID: 12109967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
    Basile VS; Ozdemir V; Masellis M; Meltzer HY; Lieberman JA; Potkin SG; Macciardi FM; Petronis A; Kennedy JL
    Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
    Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia.
    Lai IC; Liao DL; Bai YM; Lin CC; Yu SC; Chen JY; Wang YC
    Neuropsychobiology; 2002; 46(4):173-5. PubMed ID: 12566932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for an association between G protein beta3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia.
    Lee HJ; Kang SG; Paik JW; Lee MS; Cho BH; Park YM; Kim W; Choi JE; Jung IK; Kim L; Lee MS
    Hum Psychopharmacol; 2007 Dec; 22(8):501-4. PubMed ID: 17726725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia.
    Park SW; Lee JG; Kong BG; Lee SJ; Lee CH; Kim JI; Kim YH
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):433-9. PubMed ID: 19457211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.
    Liou YJ; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Mo GH; Lai IC
    Am J Med Genet B Neuropsychiatr Genet; 2009 Mar; 150B(2):239-42. PubMed ID: 18548510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
    Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.
    Liou YJ; Wang YC; Chen JY; Bai YM; Lin CC; Liao DL; Chen TT; Chen ML; Mo GH; Lai IC
    Psychiatry Res; 2007 Dec; 153(3):271-5. PubMed ID: 17669510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia.
    Pae CU; Yu HS; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):495-500. PubMed ID: 15151706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.
    Lai IC; Mo GH; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
    Eur J Clin Pharmacol; 2011 Apr; 67(4):383-388. PubMed ID: 21181138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.
    Kang SG; Choi JE; An H; Lim SW; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Lee MS; Joe SH; Jung IK; Kim L
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1545-8. PubMed ID: 18602732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia.
    Segman RH; Goltser T; Heresco-Levy U; Finkel B; Shalem R; Schlafman M; Yakir A; Greenberg D; Strous R; Lerner A; Shelevoy A; Lerer B
    Pharmacogenomics J; 2003; 3(5):277-83. PubMed ID: 14583797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.
    Zai CC; Hwang RW; De Luca V; Müller DJ; King N; Zai GC; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):639-51. PubMed ID: 16959057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study between glutathione S-transferase GST-M1, GST-T1, and GST-P1 polymorphisms and tardive dyskinesia.
    Kang SG; Lee HJ; Choi JE; An H; Rhee M; Kim L
    Hum Psychopharmacol; 2009 Jan; 24(1):55-60. PubMed ID: 19051221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association analysis of a neural nitric oxide synthase gene polymorphism and antipsychotics-induced tardive dyskinesia in Chinese schizophrenic patients.
    Wang YC; Liou YJ; Liao DL; Bai YM; Lin CC; Yu SC; Chen JY
    J Neural Transm (Vienna); 2004 May; 111(5):623-9. PubMed ID: 15088155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.